{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:41:45Z","timestamp":1792154505036,"version":"4.4.0"},"reference-count":118,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.5551\/jat.rv17031","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T18:29:16Z","timestamp":1552328956000},"page":"303-314","source":"Crossref","is-referenced-by-count":102,"title":["Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases"],"prefix":"10.5551","volume":"26","author":[{"given":"Hisanori","family":"Horiuchi","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Doman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kokame","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Saiki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion Medicine, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sadler JE: Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem, 1998; 67: 395-424","DOI":"10.1146\/annurev.biochem.67.1.395"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Rondaij MG, Bierings R, Kragt A, van Mourik JA and Voorberg J: Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol, 2006; 26: 1002-1007","DOI":"10.1161\/01.ATV.0000209501.56852.6c"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) El-Sayed MS, Sale C, Jones PG and Chester M: Blood hemostasis in exercise and training. Med Sci Sports Exerc, 2000; 32: 918-925","DOI":"10.1097\/00005768-200005000-00007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) van Loon JE, Sonneveld MA, Praet SF, de Maat MP and Leebeek FW: Performance related factors are the main determinants of the von Willebrand factor response to exhaustive physical exercise. PloS One, 2014; 9: e91687","DOI":"10.1371\/journal.pone.0091687"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Pottinger BE, Read RC, Paleolog EM, Higgins PG and Pearson JD: von Willebrand factor is an acute phase reactant in man. Throm Res, 1989; 53: 387-394","DOI":"10.1016\/0049-3848(89)90317-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chen J and Chung DW: Inflammation, von Willebrand factor, and ADAMTS13. Blood, 2018; 132: 141-147","DOI":"10.1182\/blood-2018-02-769000"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bremme KA: Haemostatic changes in pregnancy. Best Pract Res Clin Haematol, 2003; 16: 153-168","DOI":"10.1016\/S1521-6926(03)00021-5"},{"key":"8","unstructured":"8) Musumeci V, Baroni S, Cardillo C, Zappacosta B, Zuppi C, Tutinelli F and Folli G: Cardiovascular reactivity, plasma markers of endothelial and platelet activity and plasma renin activity after mental stress in normals and hypertensives. J Hypertens Suppl, 1987; 5: S1-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H and Jern S: Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost, 1989; 62: 767-771","DOI":"10.1055\/s-0038-1646899"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Konkle BA: Von Willebrand factor and aging. Semin Thromb Hemost, 2014; 40: 640-644","DOI":"10.1055\/s-0034-1389079"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Jr. and Montgomery RR: The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood, 1987; 69: 1691-1695","DOI":"10.1182\/blood.V69.6.1691.1691"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wang Z, Dou M, Du X, Ma L, Sun P, Cao H, Ye S, Jiang P, Liu F, Lin F, Zhang R and Li C: Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. PeerJ, 2017; 5: e3156","DOI":"10.7717\/peerj.3156"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nichols TC, Bellinger DA, Tate DA, Reddick RL, Read MS, Koch GG, Brinkhous KM and Griggs TR: von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand\u2019s disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis, 1990; 10: 449-461","DOI":"10.1161\/01.ATV.10.3.449"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nichols TC, Bellinger DA, Reddick RL, Smith SV, Koch GG, Davis K, Sigman J, Brinkhous KM, Griggs TR and Read MS: The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A. Blood, 1993; 81: 2644-2651","DOI":"10.1182\/blood.V81.10.2644.bloodjournal81102644"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M and et al.: Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA, 1995; 92: 2455-2459","DOI":"10.1073\/pnas.92.7.2455"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A and Jude B: Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med, 2003; 349: 343-349","DOI":"10.1056\/NEJMoa022831"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cramer EM, Meyer D, le Menn R and Breton-Gorius J: Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood, 1985; 66: 710-713","DOI":"10.1182\/blood.V66.3.710.710"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG and Sixma JJ: A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost, 1996; 75: 950-958","DOI":"10.1055\/s-0038-1650400"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ruggeri ZM: von Willebrand factor. J Clin Invest, 1997; 99: 559-564","DOI":"10.1172\/JCI119195"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lombardo VT, Hodson E, Roberts JR, Kunicki TJ, Zimmerman TS and Ruggeri ZM: Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb\/IIIa complex as demonstrated by monoclonal antibody. J Clin Invest, 1985; 76: 1950-1958","DOI":"10.1172\/JCI112193"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Litjens PE, Van Willigen G, Weeterings C, Ijsseldijk MJ, Van Lier M, Koivunen E, Gahmberg CG and Akkerman JW: A tripeptide mimetic of von Willebrand factor residues 981-983 enhances platelet adhesion to fibrinogen by signaling through integrin alpha(IIb)beta3. J Thromb Haemost, 2005; 3: 1274-1283","DOI":"10.1111\/j.1538-7836.2005.01408.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Phillips DR, Charo IF, Parise LV and Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood, 1988; 71: 831-843","DOI":"10.1182\/blood.V71.4.831.bloodjournal714831"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bennett JS: Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest, 2005; 115: 3363-3369","DOI":"10.1172\/JCI26989"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kolodziejczyk J and Ponczek MB: The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol, 2013; 17: 113-119","DOI":"10.5114\/wo.2013.34611"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Saenko EL and Scandella D: A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J Biol Chem, 1995; 270: 13826-13833","DOI":"10.1074\/jbc.270.23.13826"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M and Yawn BP: von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia, 2008; 14: 171-232","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol, 1990; 6: 217-246","DOI":"10.1146\/annurev.cellbio.6.1.217"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Furlan M: Von Willebrand factor: molecular size and functional activity. Ann Hematol, 1996; 72: 341-348","DOI":"10.1007\/s002770050184"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE and Fujikawa K: Structure of von Willebrand factorcleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem, 2001; 276: 41059-41063","DOI":"10.1074\/jbc.C100515200"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto TA, Mori T, Wanaka A, Fukui H and Fujimura Y: Localization of ADAMTS13 to the stellate cells of human liver. Blood, 2005; 106: 922-924","DOI":"10.1182\/blood-2005-01-0152"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Matsumoto M, Kawaguchi S, Ishizashi H, Yagi H, Iida J, Sakaki T and Fujimura Y: Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb, 2005; 34: 35-40","DOI":"10.1159\/000088546"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P and Lammle B: Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 1997; 89: 3097-3103","DOI":"10.1182\/blood.V89.9.3097"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB and Working Party on von Willebrand Disease C: Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost, 2006; 4: 2103-2114","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE and Subcommittee on von Willebrand F: Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost, 2000; 84: 345-349","DOI":"10.1055\/s-0037-1614018"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Castaman G and Rodeghiero F: Acquired transitory von Willebrand syndrome with ciprofloxacin. Lancet, 1994; 343: 492","DOI":"10.1016\/S0140-6736(94)92748-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Maas D, Laros-van Gorkom B, Gianotten S, Cruijsen M, van Heerde W and Nijziel M: Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma. Case Reports in Hematology, 2018; 2018: 7973297","DOI":"10.1155\/2018\/7973297"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Mohri H: Acquired von Willebrand disease in patients with polycythemia rubra vera. Am J Hematol, 1987; 26: 135-146","DOI":"10.1002\/ajh.2830260204"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W and Berneman Z: Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol, 2001; 14: 401-436","DOI":"10.1053\/beha.2001.0141"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Scott JP, Montgomery RR, Tubergen DG and Hays T: Acquired von Willebrand\u2019s disease in association with Wilm\u2019s tumor: regression following treatment. Blood, 1981; 58: 665-669","DOI":"10.1182\/blood.V58.4.665.bloodjournal584665"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sampson BM, Greaves M, Malia RG and Preston FE: Acquired von Willebrand\u2019s disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol, 1983; 54: 233-244","DOI":"10.1111\/j.1365-2141.1983.tb02091.x"},{"key":"41","unstructured":"41) Rao KP, Kizer J, Jones TJ, Anunciado A, Pepkowitz SH and Lazarchick J: Acquired von Willebrand\u2019s syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med, 1988; 112: 47-50"},{"key":"42","unstructured":"42) Soff GA and Green D: Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med, 1993; 121: 424-430"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Federici AB: Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Semin Thromb Hemost, 2011; 37: 35-40","DOI":"10.1055\/s-0030-1270069"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Tamura T, Horiuchi H, Imai M, Tada T, Shiomi H, Kuroda M, Nishimura S, Takahashi Y, Yoshikawa Y, Tsujimura A, Amano M, Hayama Y, Imamura S, Onishi N, Tamaki Y, Enomoto S, Miyake M, Kondo H, Kaitani K, Izumi C, Kimura T and Nakagawa Y: Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index. J Atheroscler Thromb, 2015; 22: 1115-1123","DOI":"10.5551\/jat.30809"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Berchtold-Herz M, Trummer G, Schlensak C and Zieger B: Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Thromb Haemost, 2010; 103: 962-967","DOI":"10.1160\/TH09-07-0497"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Jenkins CS, Clemetson KJ and Luscher EF: Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets. J Lab Clin Med, 1979; 93: 220-231","DOI":"10.1055\/s-0039-1687029"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Trossaert M, Ternisien C, Lefrancois A, Llopis L, Goudemand J, Sigaud M, Fouassier M and Caron C: Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease. Clinical and applied thrombosis\/hemostasis: Clin Appl Thromb Hemost, 2011; 17: E25-29","DOI":"10.1177\/1076029610379848"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Geisen U, Zieger B, Nakamura L, Weis A, Heinz J, Michiels JJ and Heilmann C: Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo. Thromb Res, 2014; 134: 246-250","DOI":"10.1016\/j.thromres.2014.04.033"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) James PD, Paterson AD, Notley C, Cameron C, Hegadorn C, Tinlin S, Brown C, O\u2019Brien L, Leggo J, Lillicrap D and Association Of Hemophilia Clinic Directors Of C: Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. J Thromb Haemost, 2006; 4: 783-792","DOI":"10.1111\/j.1538-7836.2006.01860.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J and Montgomery RR: Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Blood, 1998; 91: 1572-1581","DOI":"10.1182\/blood.V91.5.1572"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, O\u2019Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, 3rd, Thomas JD and American College of Cardiology\/American Heart Association Task Force on Practice G: 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014; 63: e57-185","DOI":"10.1161\/CIR.0000000000000031"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjogren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S and Zamorano JL: 2017 ESC\/EACTS Guidelines for the Management of Valvular Heart Disease. Rev Esp Cardiol (English ed), 2018; 71: 110","DOI":"10.1016\/j.rec.2017.12.013"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Bonow RO, Brown AS, Gillam LD, Kapadia SR, Kavinsky CJ, Lindman BR, Mack MJ, Thourani VH, Dehmer GJ, Bonow RO, Lindman BR, Beaver TM, Bradley SM, Carabello BA, Desai MY, George I, Green P, Holmes DR, Jr., Johnston D, Leipsic J, Mick SL, Passeri JJ, Piana RN, Reichek N, Ruiz CE, Taub CC, Thomas JD, Turi ZG, Doherty JU, Dehmer GJ, Bailey SR, Bhave NM, Brown AS, Daugherty SL, Dean LS, Desai MY, Duvernoy CS, Gillam LD, Hendel RC, Kramer CM, Lindsay BD, Manning WJ, Mehrotra P, Patel MR, Sachdeva R, Wann LS, Winchester DE and Allen JM: ACC\/AATS\/AHA\/ASE\/EACTS\/HVS\/SCA\/SCAI\/SCCT\/SCMR\/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Soc Echocardiogr, 2018; 31: 117-147","DOI":"10.1016\/j.echo.2017.10.020"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Heyde EC: Gastrointestinal bleeding in aortic stenosis. N Engl J Med, 1958; 259: 196","DOI":"10.1056\/NEJM195807242590416"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Warkentin TE, Moore JC and Morgan DG: Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand\u2019s disease the link? Lancet, 1992; 340: 35-37","DOI":"10.1016\/0140-6736(92)92434-H"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Shoenfeld Y, Eldar M, Bedazovsky B, Levy MJ and Pinkhas J: Aortic stenosis associated with gastrointestinal bleeding. A survey of 612 patients. Am Heart J, 1980; 100: 179-182","DOI":"10.1016\/0002-8703(80)90113-1"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Yoshida K, Tobe S, Kawata M and Yamaguchi M: Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg, 2006; 81: 490-494","DOI":"10.1016\/j.athoracsur.2005.07.074"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Steger AC, Galland RB, Hemingway A, Wood CB and Spencer J: Gastrointestinal haemorrhage from a second source in patients with colonic angiodysplasia. Br J Surg, 1987; 74: 726-727","DOI":"10.1002\/bjs.1800740824"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Perkins HA: Correction of the hemostatic defects in Von Willebrand\u2019s disease. Blood, 1967; 30: 375-380","DOI":"10.1182\/blood.V30.3.375.375"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Spangenberg T, Budde U, Schewel D, Frerker C, Thielsen T, Kuck KH and Schafer U: Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2015; 8: 692-700","DOI":"10.1016\/j.jcin.2015.02.008"},{"key":"61","unstructured":"61) Marggraf O, Schneppenheim S, Daubmann A, Budde U, Seiffert M, Reichenspurner H, Treede H, Blankenberg S and Diemert P: Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation. J Invasive Cardiol, 2014; 26:654-658"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Caspar T, Jesel L, Desprez D, Grunebaum L, Samet H, Trinh A, Petit-Eisenmann H, Kindo M, Ohlmann P and Morel O: Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor. Can J Cardiol, 2015; 31: 738-743","DOI":"10.1016\/j.cjca.2015.01.012"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Yamashita K, Yagi H, Hayakawa M, Abe T, Hayata Y, Yamaguchi N, Sugimoto M, Fujimura Y, Matsumoto M and Taniguchi S: Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. J Atheroscler Thromb, 2016; 23: 1150-1158","DOI":"10.5551\/jat.34421"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Kokame K: Subsequent Response of VWF and ADAMTS13 to Aortic Valve Replacement. J Atheroscler Thromb, 2016; 23: 1141-1143","DOI":"10.5551\/jat.ED055"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Blackshear JL: Gastrointestinal Bleeding in Native and Prosthetic Valve Disease. Curr Treat Options Cardiovasc Med, 2018; 20: 6","DOI":"10.1007\/s11936-018-0595-1"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Uchida T, Hamasaki A, Ohba E, Yamashita A, Hayashi J and Sadahiro M: Life-threatening subdural hematoma after aortic valve replacement in a patient with Heyde syndrome: a case report. J Cardiothorac Surg, 2017; 12: 65","DOI":"10.1186\/s13019-017-0629-x"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Panza JA, Petrone RK, Fananapazir L and Maron BJ: Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol, 1992; 19: 91-99","DOI":"10.1016\/0735-1097(92)90057-T"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Pruthi RK: Hypertrophic obstructive cardiomyopathy, acquired von Willebrand syndrome, and gastrointestinal bleeding. Mayo Clin Proc, 2011; 86: 181-182","DOI":"10.4065\/mcp.2011.0023"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Blackshear JL, Schaff HV, Ommen SR, Chen D and Nichols WL: Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy. Mayo Clin Proc, 2011; 86: 219-224","DOI":"10.4065\/mcp.2010.0309"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Wake M, Takahashi N, Yoshitomi H and Tanabe K: A case of hypertrophic obstructive cardiomyopathy and acquired von Willebrand syndrome: response to medical therapy. J Echocardiogr, 2014; 12: 112-114","DOI":"10.1007\/s12574-014-0215-3"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Onimoe G, Grooms L, Perdue K and Ruymann F: Acquired von Willebrand Syndrome in congenital heart disease: does it promote an increased bleeding risk? Br J Haematol, 2011; 155: 622-624","DOI":"10.1111\/j.1365-2141.2011.08732.x"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Waldow HC, Westhoff-Bleck M, Widera C, Templin C and von Depka M: Acquired von Willebrand syndrome in adult patients with congenital heart disease. Int J Cardiol, 2014; 176: 739-745","DOI":"10.1016\/j.ijcard.2014.07.104"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Loeffelbein F, Funk D, Nakamura L, Zieger B, Grohmann J, Siepe M, Kroll J and Stiller B: Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease. Interact Cardiovasc Thorac Surg, 2014; 19: 926-932","DOI":"10.1093\/icvts\/ivu305"},{"key":"74","unstructured":"74) Geggel RL, Carvalho AC, Hoyer LW and Reid LM: von Willebrand factor abnormalities in primary pulmonary hypertension. Am Rev Respir Dis, 1987; 135: 294-299"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Lopes AA, Maeda NY, Aiello VD, Ebaid M and Bydlowski SP: Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Chest, 1993; 104: 1455-1460","DOI":"10.1378\/chest.104.5.1455"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Veyradier A, Nishikubo T, Humbert M, Wolf M, Sitbon O, Simonneau G, Girma JP and Meyer D: Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension. Circulation, 2000; 102: 2460-2462","DOI":"10.1161\/01.CIR.102.20.2460"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Robinson JC, Pugliese SC, Fox DL and Badesch DB: Anticoagulation in Pulmonary Arterial Hypertension. Curr Hypertens Rep, 2016; 18: 47","DOI":"10.1007\/s11906-016-0657-2"},{"key":"78","unstructured":"78) Yuceoglu YZ, Dresdale DT, Valensi QJ, Narvas RM and Gottlieb NT: Primary pulmonary hypertension with hoarseness and massive (fatal) hemoptysis. Review of the literature and report of a case. Vascular Diseases, 1967; 4: 290-304"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Koyama N, Matsumoto M, Tamaki S, Yoshikawa M, Fujimura Y and Kimura H: Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. Eur Respir J, 2012; 40: 657-664","DOI":"10.1183\/09031936.00186210"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Shapiro BP, Ung S, Stark ME, Parikh P, Johns GS and Chen D: Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation. J Thromb Haemost, 2014; 12: 1966-1974","DOI":"10.1111\/jth.12734"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Wan SH, Liang JJ, Vaidya R, Blackshear JL and Chen D: Acquired Von Willebrand syndrome secondary to mitral and aortic regurgitation. Can J Cardiol, 2014; 30: 1108. e1109-1108. e1110","DOI":"10.1016\/j.cjca.2014.02.010"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S and Zieger B: Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb, 2015; 22: 265-271","DOI":"10.5551\/jat.27268"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Goto S: Acquired von Willebrand Syndrome (AVWS) as an important diagnostic category of disease. J Atheroscler Thromb, 2015; 22: 231-232","DOI":"10.5551\/jat.ED009"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A and Zieger B: Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. J Heart Lung Transplant, 2018; 37: 985-991","DOI":"10.1016\/j.healun.2018.03.013"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G, Berchtold-Herz M, Schlensak C and Zieger B: Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med, 2012; 38: 62-68","DOI":"10.1007\/s00134-011-2370-6"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Tamura T, Horiuchi H, Obayashi Y, Fuki M, Imanaka M, Kuroda M, Nishimura S, Amano M, Sakamoto J, Tamaki Y, Enomoto S, Miyake M, Kondo H, Izumi C and Nakagawa Y: Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation. Cardiovasc Interv Ther, 2019; in press","DOI":"10.1007\/s12928-019-00568-y"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC and Poirier VL: Long-term use of a left ventricular assist device for endstage heart failure. N Engl J Med, 2001; 345: 1435-1443","DOI":"10.1056\/NEJMoa012175"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Hata H, Fujita T, Shimahara Y, Sato S, Yanase M, Seguchi O, Sato T, Nakatani T and Kobayashi J: Early and mid-term outcomes of left ventricular assist device implantation and future prospects. Gen Thorac Cardiovasc Surg, 2015; 63: 557-564","DOI":"10.1007\/s11748-015-0538-7"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB and Naftel DC: Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant, 2017; 36: 1080-1086","DOI":"10.1016\/j.healun.2017.07.005"},{"key":"90","unstructured":"90) J-MACS: Japanese registry for Mechanically Assisted Circulatory Support. (Japanese) http:\/\/www.pmda.go.jp\/safety\/surveillance-analysis\/0009.html. Accessed October 10, 2018."},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Nakatani T, Sase K, Oshiyama H, Akiyama M, Horie M, Nawata K, Nishinaka T, Tanoue Y, Toda K, Tozawa M, Yamazaki S, Yanase M, Ohtsu H, Ishida M, Hiramatsu A, Ishii K and Kitamura S: Japanese registry for Mechanically Assisted Circulatory Support: First report. J Heart Lung Transplant, 2017; 36: 1087-1096","DOI":"10.1016\/j.healun.2017.08.002"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) Draper KV, Huang RJ and Gerson LB: GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc, 2014; 80: 435-446. e431","DOI":"10.1016\/j.gie.2014.03.040"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Slaughter MS: Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res, 2010; 3: 618-624","DOI":"10.1007\/s12265-010-9222-6"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC and Frazier OH: Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant, 2011; 30: 849-853","DOI":"10.1016\/j.healun.2011.03.008"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) Sakatsume K, Akiyama M, Saito K, Kawamoto S, Horiuchi H and Saiki Y: Intractable bleeding tendency due to acquired von Willebrand syndrome after Jarvik 2000 implant. J Artif Organs, 2016; 19: 289-292","DOI":"10.1007\/s10047-016-0896-7"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Sakatsume K, Saito K, Akiyama M, Sasaki K, Kawatsu S, Takahashi G, Adachi O, Kawamoto S, Horiuchi H and Saiki Y: Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation. Eur J Cardiothorac Surg, 2018; 54: 841-846","DOI":"10.1093\/ejcts\/ezy172"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97) Meyer AL, Malehsa D, Budde U, Bara C, Haverich A and Strueber M: Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. JACC Heart Fail, 2014; 2: 141-145","DOI":"10.1016\/j.jchf.2013.10.008"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Muslem R, Caliskan K and Leebeek FWG: Acquired coagulopathy in patients with left ventricular assist devices. J Thromb Haemost, 2018; 16: 429-440","DOI":"10.1111\/jth.13933"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) Bourque K, Cotter C, Dague C, Harjes D, Dur O, Duhamel J, Spink K, Walsh K and Burke E: Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility. ASAIO J, 2016; 62: 375-383","DOI":"10.1097\/MAT.0000000000000388"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100) Mehra MR, Goldstein DJ, Uriel N, Cleveland JC, Jr., Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O\u2019Connell JB, Heatley G, Sood P and Naka Y: Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med, 2018; 378: 1386-1395","DOI":"10.1056\/NEJMoa1800866"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101) Ueno S, Nakase H, Kasahara K, Uza N, Kitamura H, Inoue S, Mikami S, Matsuura M and Chiba T: Clinical features of Japanese patients with colonic angiodysplasia. J Gastroenterol Hepatol, 2008; 23: e363-366","DOI":"10.1111\/j.1440-1746.2007.05126.x"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102) Sharma R and Gorbien MJ: Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients. Arch Intern Med, 1995; 155: 807-812","DOI":"10.1001\/archinte.155.8.807"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103) Nubret K, Mauriat P, Roubertie F, James C, Tafer N and Ouattara A: Acquired von Willebrand disease in a child with a ventricular assist device. J Thorac Cardiovasc Surg, 2013; 146: e30-32","DOI":"10.1016\/j.jtcvs.2013.06.023"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104) Costello JP, Diab YA, Philippe-Auguste M, Jones MB, Shankar V, Friedman KD and Nath DS: Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature review. World J Pediatr Congenit Heart Surg, 2014; 5: 592-598","DOI":"10.1177\/2150135114539521"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105) Bauditz J and Lochs H: Angiogenesis and vascular mal formations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J Gastroenterol, 2007; 13: 5979-5984","DOI":"10.3748\/wjg.v13.45.5979"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106) Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med, 2000; 6: 389-395","DOI":"10.1038\/74651"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107) Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN and Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 1996; 87: 1171-1180","DOI":"10.1016\/S0092-8674(00)81813-9"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108) Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC and Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 1996; 87: 1161-1169","DOI":"10.1016\/S0092-8674(00)81812-7"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109) Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN and Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 1997; 277: 55-60","DOI":"10.1126\/science.277.5322.55"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110) Zhang ZG, Zhang L, Jiang Q and Chopp M: Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res, 2002; 90: 284-288","DOI":"10.1161\/hh0302.104460"},{"key":"111","unstructured":"111) Brandao D, Costa C, Canedo A, Vaz G and Pignatelli D: Endogenous vascular endothelial growth factor and angiopoietin-2 expression in critical limb ischemia. International angiology: Int Angiol, 2011; 30: 25-34"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112) Junquera F, Saperas E, de Torres I, Vidal MT and Malagelada JR: Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol, 1999; 94: 1070-1076","DOI":"10.1111\/j.1572-0241.1999.01017.x"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113) Holleran G, Hall B, O\u2019Regan M, Smith S and McNamara D: Expression of Angiogenic Factors in Patients With Sporadic Small Bowel Angiodysplasia. J Clin Gastroenterol, 2015; 49: 831-836","DOI":"10.1097\/MCG.0000000000000260"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114) Kang J, Hennessy-Strahs S, Kwiatkowski P, Bermudez CA, Acker MA, Atluri P, McConnell PI and Bartoli CR: Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia. Circ Res, 2017; 121: 963-969","DOI":"10.1161\/CIRCRESAHA.117.310848"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115) Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA and Randi AM: Endothelial von Willebrand factor regulates angiogenesis.Blood, 2011; 117: 1071-1080","DOI":"10.1182\/blood-2010-01-264507"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116) Fressinaud E and Meyer D: International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost, 1993; 70: 546","DOI":"10.1055\/s-0038-1649623"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117) Satoh Y, Kita H, Kihira K, Mutoh H, Osawa H, Satoh K, Ido K, Sakata Y and Sugano K: Gastrointestinal angiodysplasia in a patient with type 2 von Willebrand\u2019s disease and analysis of exon 28 of the von Willebrand factor gene. Am J Gastroenterol, 2004; 99: 2495-2498","DOI":"10.1111\/j.1572-0241.2004.40459.x"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118) Makris M: Gastrointestinal bleeding in von Willebrand disease. Thromb Res, 2006; 118 Suppl 1: S13-17","DOI":"10.1016\/j.thromres.2006.01.022"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/4\/26_RV17031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:36:27Z","timestamp":1574296587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/4\/26_RV17031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv17031","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}